New Molecular Entities approved by FDA
1. Vyvanse – New River Pharmaceuticals
2. Tekturna – Novartis
3. Tykerb – GlaxoSmithKline
4. Altabax – GlaxoSmithKline
5. Neupro – Schwarz BioSciences
6. Torisel – Wyeth
[...continue reading below...]
7. Letairis – Gilead Sciences
8. Selzentry – Pfizer
9. Ammonia N 13 – Feinstein
10. Somatuline Depot – Biomeasure
11. Doribax – Johnson & Johnson
12. Isentress – Merck
13. Ixempra – Bristol-Myers Squibb
14. Tasigna – Novartis
15. Kuvan – BioMarin
16. Bystolic – Mylan Bertek
New Biologics approved by FDA
17. Soliris -Alexion
18. Mircera – Hoffman-La Roche
